About Us

PsyBio Therapeutics is developing biosynthetic psychoactive compounds that offer a new paradigm of treatment to reverse the course of mental health issues. 

​

Psychoactive medications treat the illness by rewiring the brain through contemplation and a change of perception in combination with psychotherapy 

vs.

Standard of care (SSRI’s, SNRI’s, MAOI’s, NDRI’s, etc…) which just chemically treat symptoms.

​

Working in collaboration with Miami University utilizing a proprietary platform technology to biologically synthesize psilocybin and other targeted next-generation active compounds in Psilocybe Cubensis and other fungi and plants.